Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment.

ABSTRACT: Antivirals already on the market and expertise gained from the SARS and MERS outbreaks are gaining momentum as the most effective way to combat the coronavirus outbreak. SARS-CoV-2 has caused considerable mortality due to respiratory failure, highlighting the immediate need for successful therapies as well as the long-term need for antivirals to combat potential emergent mutants of coronaviruses. There are constant viral mutations are being observed due to which world is experiencing different waves of SARS-CoV-2. If our understanding of the virology and clinical presentation of COVID-19 grows, so does the pool of possible pharmacological targets. In COVID-19, the difficulties of proper analysis of current pre-clinical/clinical data as well as the creation of new evidence concerning drug r

SUBMITTER: Chavda VP 

PROVIDER: S-EPMC8532500 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature